PRODUCTS

INTERNATIONAL  /  
ALEDRONATE + CHOLECALCIFEROL
«  BACK TO "INTERNATIONAL"

Alendronate and Cholecalciferol is indicated for the treatment of postmenopausal osteoporosis in patients at risk of vitamin D insufficiency.

Alendronate and Cholecalciferol reduces the risk of vertebral and hip fractures.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Aledronate + Cholecalciferol
  • Tablets

  • 70mg/2800IU

  • 70mg/5600IU

  • Bone Metabolism-Osteoporosis

Other products in "International"